Cardiovascular

Latest News

Abelacimab Demonstrates Safety and Efficacy for Patients With AFib of All Ages: Sid Patel, MD

By Kyle Munz
Siddharth M. Patel, MD, MPH

April 24th 2025

The continued success of abelacimab throughout the AZALEA-TIMI 71 trials helps draw the drug closer to FDA approval, stated Sid Patel, MD.

One's ZIP code can greatly influence care access | image credit: Syda Productions - stock.adobe.com

"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health

By Kyle Munz
Antoine Keller, MD, FACC, FACS

April 18th 2025

Lp(a) and Getting a Head Start Against Heart Disease: Jeremy Wigginton, MD

By Kyle Munz
Jeremy Wigginton, MD

April 8th 2025

High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment

By Giuliana Grossi
Christian Ruff, MD

April 4th 2025

Heart disease is, and has been, the number 1 cause of death for Americans over the last century | image credit: Thirakun - stock.adobe.com

Digital Solutions Can Transform CVD Care, Prevention

By Kyle Munz

April 2nd 2025

Lipoprotein(a) and Cardiovascular Risk

Learn about more about lipoprotein(a), including how to improve patient outcomes through better screening and management.

Watch Now

Continuing Medical Education

View All

May 1st 2025

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases

May 1st 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

May 1st 2025

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

1.0 Credit / Cardiology

More News

August 27th 2018

ASCEND Results Confirm Aspirin Prevents Primary Vascular Events in Diabetes

Surabhi Dangi-Garimella, PhD

Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ongoing ESC Congress in Munich, Germany.

August 27th 2018

What We're Reading: Protections for Pre-existing Conditions; Shareholders Approve Cigna–Express Scripts Deal; Aspirin and CV Risk

AJMC Staff

GOP senators have introduced legislation they say would protect provisions for preexisting conditions under the Affordable Care Act; Cigna shareholders have voted in favor of the acquisition of pharmacy benefit manager Express Scripts; and study results show that aspirin does not lower cardiovascular (CV) risk in the long-term.

August 24th 2018

Drug Prices Not Consistently Aligned With Value, Analysis Finds

Jaime Rosenberg

A Health Affairs analysis showed a wide range of cost-effectiveness estimates for 30 of the most commonly prescribed cardiovascular drugs, suggesting that drug pricing is not consistently aligned with value.

August 10th 2018

AJMC® in the Press, August 10, 2018

AJMC Staff

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

August 10th 2018

Patient and Physician Predictors of Hyperlipidemia Screening and Statin Prescription

Sneha Kannan, MD David A. Asch, MD, MBA Gregory W. Kurtzman, BA Steve Honeywell Jr, BS Susan C. Day, MD, MPH Mitesh S. Patel, MD, MBA, MS

Physician and patient predictors of hyperlipidemia screening and statin prescription at a large, multihospital regional health center based on electronic health record data.

July 27th 2018

Oncology, CVD, Infectious Disease Most Common Areas for Outcomes-Based Contracts, Avalere Finds

Laura Joszt, MA

Health plans continue to show interest in expanding outcomes-based contracts, according to an Avalere Health study that also found cardiovascular diseases, infectious diseases, and oncology represent the most common therapeutic areas to have these contracts.

July 19th 2018

Swapping Metformin for Sulfonylureas Boosts CV Risk in Type 2 Diabetes, Study Finds

Mary Caffrey

Sulfonylureas are an older class of type 2 diabetes therapy but remain the most commonly prescribed antidiabetic drug after metformin.

July 12th 2018

Direct Oral Anticoagulant Prescription Trends, Switching Patterns, and Adherence in Texas Medicaid

Shui Ling Wong, MS Landon Z. Marshall, PharmD Kenneth A. Lawson, PhD

Direct oral anticoagulants (DOACs) are associated with increased prescription costs. Actual practice data show a high switch rate and poor adherence among DOAC initiators that need to be addressed.

June 29th 2018

Population-Level Health Initiatives Can Improve Health and Reduce Risk of Heart Disease in a Community

Laura Joszt, MA

Findings from a 10-year research project show that implementing health initiatives at a population level can improve health and reduce the risk of heart disease for an entire community.

June 4th 2018

Want to Live Longer? Pick Up the Pace, Study Says

Mary Caffrey

Public health messaging has typically focused on the volume of walking not the intensity. This study suggests for those with limited time, a faster pace could make a difference.

May 23rd 2018

Under 2017 Guideline, More Than 105 Million Americans Have Hypertension

Kelly Davio

The number of US adults who have high blood pressure could grow by as much as 31 million—and the number of adults who will be recommended for antihypertensive treatment could increase by 11 million—if full implementation of the American Heart Association’s 2017 hypertension guideline is reached.

May 16th 2018

Quality of Cardiovascular Care May Vary Substantially Across the VA System

Kelly Davio

The authors write that these differences among Veterans Affairs (VA) populations could reflect variability across the medical centers in terms of quality of care, adherence to evidence-based treatment and screening guidelines, access to urgent care, posthospitalization care protocols, chronic disease management, and access to specialty care, social work services, and behavioral health care.

May 4th 2018

5 Things to Know About the Praluent–Express Scripts Deal

Mary Caffrey

This week's announcement comes after cardiologists have spent several years sharing accounts of their difficulty gaining access to PCSK9 inhibitors for their patients.

May 2nd 2018

Women Are Still Underrepresented in Clinical Trials for Cardiovascular Disease Drugs

Kelly Davio

While cardiovascular disease (CVD) is the leading cause of death among women as well as men, and while both sex and gender differences in CVD and its treatments have been well documented, women continue to be less represented than men in clinical trials of drugs to treat CVD. Among proposed reasons for this phenomenon are the recruitment of younger patients, inclusion criteria that tend to select men, and exclusion criteria that are more common in women.

May 1st 2018

Research Provides Insight Into Cardiac-Related Mortality in Huntington Disease

Kelly Davio

Huntington disease (HD) is an incurable, inherited neurological disorder caused by the mutant Huntingtin gene, which produces a mutant form of Huntingtin protein (mHTT). In addition to creating the profound neurological impacts of HD, the mHTT protein also impairs other organ systems, and new research, published in Cell Reports, suggests that the protein may play a role in cardiac-related mortality in patients with HD.

April 30th 2018

Women With Migraine More Likely to Develop Hypertension

Jaime Rosenberg

Women with a past history of migraine have a 15% higher risk of developing hypertension than those with no history of migraine, according to study findings published in Cephalalgia.

April 23rd 2018

JAMA Comparison: SGLT2 Inhibitors, GLP-1 Agonists Offer Lower Mortality in Type 2 Diabetes

Mary Caffrey

Guidance for primary care physicians prescribing type 2 diabetes therapies comes at an opportune time. A major rift over guidelines for glycemic control has opened between the American College of Physicians, a professional association of internists, and diabetes specialists, including endocrinologists and diabetes educators.

April 19th 2018

Marital Status and SES Associated With Higher Risk of Second Heart Attack, Stroke

Laura Joszt, MA

Divorce and socioeconomic status (SES)—measured by disposable income and education—predict patients who survived a heart attack who are at higher risk of a second event.

April 11th 2018

Reports Highlight Impact of Taxing Unhealthy Products to Combat Chronic Diseases Worldwide

Laura Joszt, MA

Papers from The Lancet's Taskforce of Non-Communicable Diseases analyzed the potential health and economic impact of implementing taxes on soda, alcohol, and tobacco to combat the rising rates of the chronic diseases worldwide.

March 19th 2018

Semaglutide Produces Significant, Sustained Weight Loss for Adults With Obesity in Phase 2 Trial

Mary Caffrey

The study compared patients taking semaglutide with those taking placebo and liraglutide, which is approved for treatment of obesity.

March 16th 2018

5 Takeaways From the American College of Cardiology Scientific Session

Mary Caffrey

Results from the ODYSSEY Outcomes trial for the PCSK9 inhibitor alirocumab were the top news at the meeting.

March 15th 2018

Medicare Hospital Discharges Decline, but Observation Stays Rise, Avalere Finds

Mary Caffrey

The report finds a connection between payment reform and hospital use patterns, but that connection may add to the debate that cardiologists have raised over the effect on patients.

March 12th 2018

BPCI Advanced, Attribution, and Other New Challenges in Payment Reform

Mary Caffrey

Coverage of the 67th Scientific Session of the American College of Cardiology.

March 12th 2018

CVD-REAL Results in More Diverse Countries Link SGLT2s to Lower Risk of Death, Heart Attack, Stroke

Mary Caffrey

CVD-REAL, the giant study of real-world evidence comparing sodium glucose co-transporter-2 (SGLT2) inhibitors with other glucose-lowering drugs to treat type 2 diabetes, found a 49% lower risk of all-cause death and a host of other benefits across 6 new, more diverse countries, the study’s lead author told a packed room Sunday at the 67th Scientific Session of the American College of Cardiology in Orlando, Florida.

March 12th 2018

Large Claims Study on DOACs Finds Less Major Bleeding, Stroke With Apixaban

Mary Caffrey

Coverage of the 67th Scientific Session of the American College of Cardiology.

March 12th 2018

For Patients With Heart Failure, Healthcare Reform Brings Change and Unintended Consequences

Mary Caffrey

Healthcare reform pledged to do better for patients with heart failure, creating the incentives and team-based approaches these fragile patients need. In some cases, this has happened, but there have also been unintended consequences, according to a panel appearing Sunday at the 67th Scientific Session of the American College of Cardiology, being held in Orlando, Florida.

March 11th 2018

Secondhand Smoke and Screen Time: Prevention Insights at ACC

Mary Caffrey

Coverage from the 67th Scientific Session of the American College of Cardiology.

March 11th 2018

A Champion of Women's Heart Health Tells How the Journey Starts With Better Data

Mary Caffrey

The journey to better women's heart health starts with having more data, said Nanette Kass Wenger, MD, MACC, MACP, FAHA, professor of cardiology at Emory University School of Medicine, during the Simon Dack Keynote Lecture, which opened the 67th Scientific Session of the American College of Cardiology.

March 6th 2018

Music Makes a Difference During Cardiac Stress Tests, Study Finds

Mary Caffrey

The study will be presented during the 67th American College of Cardiology Scientific Session in Orlando, Florida.

March 1st 2018

Several Walks a Week Can Protect Women From Heart Failure After Menopause

Mary Caffrey

A study being presented at the upcoming meeting of the American College of Cardiology found a dose–response relationship between walking and reduced heart failure risk.

...

8 9 10 11 12 13 14 15 16

...

24 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions